BioSpace News Archive

OBI Pharma, Inc. announced scientific data highlighting the antitumor synergy of OBI-3424 in combination with pembrolizumab and the association of high Globo H and PD-L1 expression resulting in poor survival in gastric cancer patients, will be presented at the American Association of Cancer Research Annual Meeting from April 8–13, 2022 in New Orleans, LA..

Enochian BioSciences, Inc. announced that Greg Duczynski is joining as Senior Vice President for Clinical Operations after a distinguished 32-year career with Pfizer.

PureTech Health plc plans to publish its annual report and financial results on Tuesday, April 26, 2022 at 2:00 AM EDT / 7:00 AM BST.

Zealand Pharma A/S announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:

SABI Mind is pleased to announce Canada’s first research partnership with U.S. based Reverie Psychedelics (Reverie).

Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform to develop therapeutics that render calcified tissue and organs supple again, announced the closing of a $10 million funding round led by Kizoo Technology Capital, a leading early-stage investor in breakthrough rejuvenation technologies.

Jazz Pharmaceuticals plc and Werewolf Therapeutics, Inc. today announced that the companies have entered into a licensing agreement under which Jazz has acquired exclusive global development and commercialization rights to Werewolf’s investigational WTX-613.

Click Therapeutics, Inc today announced that Randall Stanicky, Chief Financial Officer, will present at Chardan’s Prescription Digital Therapeutics Summit on Monday, April 11, 2022 at 2:30 p.m. ET.

Vizgen today announced that it will be presenting a poster at the 2022 American Association for Cancer Research (AACR) Annual Meeting.

Moderna, Inc. today announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health threats.